The Organization for Professionals in Regulatory Affairs (TOPRA) awarded Quintiles the “Support Award” on Nov. 18 to recognize the company’s critical role in the drug development process.
The selection committee for the awards included a panel of senior decision-makers ranging from biopharmaceutical companies, academia and various regulatory agencies.
The selection committee said, “The Quintiles team provided high-quality regulatory science, strategy and operational support for a very challenging indication area, which is a significant public health problem globally. Their integrated support, working closely with the sponsor, has resulted in a pioneering approval. They demonstrated great teamwork and a creative regulatory approach.”